Related Experiment Video
Updated: May 10, 2026
05:51
Measuring Diaphragm Thickness and Function Using Point-of-Care Ultrasound
Published on: November 3, 2023
Diaphragm weakness in mechanically ventilated critically ill patients.
Critical Care (London, England)
|June 22, 2013
Summary
Infection causes diaphragm weakness in mechanically ventilated patients, leading to poor outcomes. Severe diaphragm weakness significantly increases mortality and prolongs mechanical ventilation duration.
Area of Science:
- Critical Care Medicine
- Respiratory Physiology
- Intensive Care Unit (ICU) Studies
Background:
- Mechanically ventilated patients frequently develop diaphragm muscle weakness.
- The causes and clinical significance of this weakness are not fully understood.
- Diaphragm weakness impacts patient outcomes, including ventilation duration and mortality.
Purpose of the Study:
- To assess diaphragm strength in mechanically ventilated medical ICU patients.
- To correlate diaphragm weakness with clinical parameters like infection.
- To examine the link between diaphragm strength and patient outcomes.
Main Methods:
- Measured transdiaphragmatic twitch pressure (PdiTw) via phrenic nerve stimulation.
- Correlated diaphragm weakness with infection, BUN, albumin, and glucose levels.
- Assessed diaphragm strength's relationship to mortality and mechanical ventilation duration.
Main Results:
- Infection is a primary risk factor for diaphragm weakness in ventilated ICU patients.
- Severe diaphragm weakness (PdiTw<10 cmH2O) was linked to higher mortality (49% vs. 7%) and longer ventilation (12.3 vs. 5.5 days).
- A significant association was found between diaphragm weakness and adverse patient outcomes.
Conclusions:
- Infection is a major cause of severe diaphragm weakness in mechanically ventilated patients.
- Diaphragm weakness is a significant predictor of poor outcomes in this population.
- Addressing diaphragm weakness may improve patient recovery and survival.
Related Concept Videos
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:23Acute Respiratory Failure-IV
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
01:10Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:29Mechanical Ventilation I: Indication and Settings
Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
01:26Pneumothorax-I
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.